No Detail Found!

Effects of Diferent Quick-Freezing Methods and Storage Temperatures on the Content of Cryoprecipitated Blood Coagulation Factors in Fresh Plasma

Author(s)
Haiyan Wen Changsha Blood Center,Changsha, 410005,China
Kai Liao Changsha Blood Center,Changsha, 410005,China
Zhengrong Yuan Xiangtan blood station,Xiangtan, 411100,China
Ning Zhou Xiangtan blood station,Xiangtan, 411100,China
Abstract
To observe the effect of different quick-freezing methods and different storage temperatures on the content of cryoprecipitated blood coagulation factors in fresh plasma. The convenient sampling method was used to select 200 ml of whole blood from 60 unpaid blood donors who entered the blood station from January 2022 to October 2022. The acquisition time is controlled within 10 min. The plasma samples were divided into six groups (A, B, C, D, E, F) by using a random number table, 10 in each group. Group A (plate freezer for 30 min, - 30 ? storage), Group B (plate freezer for 30 min, 4 ? storage), Group C (plate freezer for 120 min, - 30 ? storage), Group D (plate freezer for 120 min, - 4 ? storage), Group E (plate freezer for 30 min, - 4 ? storage), Group F (plate freezer for 120 min, 4 ? storage). At 0, 3, 5, 7 and 9 h after the completion of the preparation of cryoprecipitate, the changes and differences of the content of coagulation factor VIII (Fv III) and fibrinogen (FIB) in the six groups of samples were observed. The highest level of FvIII occurred in group B at 5 h with a concentration of (2.47±0.56) IU/mL, while the lowest level occurred in group A at 9 h with a concentration of (0.84±0.07) IU/mL. The highest level of FIB occurred in group A at 0 h with a concentration of (245.56±25.92) mg/200ml, while the lowest level occurred in group C at 9 h with a concentration of (195.16±13.98) mg/200ml. It is preferable that both FvIII and FIB levels are at a higher level at 9 h, with group B having more appropriate levels of FvIII and FIB. According to the analysis of variance, the content of FvIII will be affected by the storage temperature, time, quick-freezing method, and the interaction between quick-freezing method and time (P<0.05). The content of FIB will be affected by the effects of quick-freezing method, time, quick-freezing method and storage temperature (P<0.05). Different quick-freezing methods and storage temperatures affect FvIII and FIB in the cryoprecipitated fresh plasma. The optimal quick-freezing method is the plate quick-freezing machine for 30min, and the storage temperature is 4?. Under this condition, the content of coagulation factor in the cryoprecipitate decreased more slowly.
Publication Details
Page(s) 99-106
Published Journal: Pakistan Journal of Zoology, Volume: 57, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
preservation, fibrinogen, Coagulation factor, Fresh plasma, Quick-frozen
References
Bahreini S.,Shahshahani H.J.,Nasizadeh S.,Ahmadinejad M. .2021 .The activity of labile coagulation factors and fibrinogen in thawed plasma during a 5 days storage period in the hospital blood bank refrigerator. Transfus. Med, 31 : 494-498.
Cadé M.,Muñoz-Garcia J.,Babuty A.,Fouassier M.,Heymann M.F.,Monahan P.E.,Heymann D. .2021 .FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasis. Drug Discov. Today, 07 : 102-116.
He Z. .2022 .Application of blood component transfusion in patients with massive blood transfusion. Chin. J. Mod. Drug Appl., 16 : 164-166.
Kobsar A.,Pfeifroth A.,Klingler P.,Niklaus M.,Schubert J.,Kuhn S.,Koessler A.,Boeck M.,Koessler J. .2022 .Composition of plasma in apheresis-derived platelet concentrates under cold storage. PMID: 35969131, : 22.
Li J.,Chen Q.,X. Q. .2014 .Research on the clinical efects of cryoprecipitate in treating infection and bleeding patients. Chin. J. Nosocomiol., 19 : 4835-4829.
Lokhandwala P.M.,Young P.P.,White J.,Brown B.L. .2022 .Cryoprecipitated anti-hemophiliac factor manufactured from plasma frozen within 24 h after phlebotomy meets AABB quality standards. Transfusion, 62 : 1731-1735.
May J.E.,Wolberg A.S.,Lim A.S. .2021 .Disorders of fibrinogen and fibrinolysis. Hematol. Oncol. Clin. N. Am., 07 : 1197-1217.
Napodano C.,Gulli F.,Rapaccini G.L.,Marino M.,Basile U. .2020 .Identification, classification, and novel biomarkers of mysterious proteins. Adv. Clin. Chem, 09 : 299-340.
Obaid O.,Anand T.,Nelson A.,Reina R.,Ditillo M.,Stewart C.,Douglas M.,Friese R.,Gries L.,Joseph B. .2022 .Fibrinogen supplementation for the trauma patient: Should you choose fibrinogen concentrate over cryoprecipitate. J. Trauma Acute Care Surg., 93 : 453-460.
Piedras J.,Sánchez-Montero P.E.,Herrera F.M.,Córdova M.S.,Sánchez-Medal L. .1993 .Efect of plasma freezing temperature, anticoagulant and time of storage on factor VIII: C activity in cryoprecipitate. Arch. Med. Res., 24 : 23-26.
Politou M.,Kontoteza I.V.,Pouliakis A.,Dryllis G.,Fortsa P.,Valsami S.,Stamoulis K. .2022 .Efect of prolonged storage on quality characteristics of recovered plasma: Is there an expiration date. Transfusion, 62 : 2188-2193.
Rapaille A.,Lotens A.,Valensart N.D.,Najdovski T.,Green L. .2021 .Evaluation of the hemostatic capacity of methylene blue-treated liquid (not frozen) plasma stored up 14 days at 2° to 6°C. , 61 : 2450-2457.
Raycraft T.,Bartoszko J.,Karkouti K.,Callum J.,Lin Y. .2022 .Practice patterns of ABO-matching for cryoprecipitate and patient outcomes after ABOcompatible versus incompatible cryoprecipitate. Vox, 117 : 1105-1111.
Rühl H.,Friemann A.M.,Reda S.,Schwarz N.,Winterhagen F.I.,Berens C.,Müller J.,Oldenburg J.,Pötzsch B. .2022 .Activated factor XI is increased in plasma in response to surgical trauma but not to recombinant activated FVII-induced thrombin formation. J. Atheroscler. Thromb., 29 : 82-98.
Song Y.B. .2019 .Release of new version of technical operating procedures for blood stations. China Med, 10 : 7.
Spivey M.A.,Jeter E.K.,Lazarchick J.,Kizer J.,Spivey L.B. .1992 .Postfiltration factor VIII and ifbrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C. , 32492263448 : 2995-343.
Stahl K.,Schmidt J.J.,Seeliger B.,Schmidt B.M.W.,Welte T.,Haller H.,Hoeper M.M.,Budde U.,Bode C.,David S. .2020 .Efect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock. Crit. Care, 24 : 71.
Thomas K.A.,Shea S.M.,Spinella P.C. .2021 .Efects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro. Transfusion, 61 : 1943-1954.
Thomson C.,Sobieraj-Teague M.,Scott D.,Duncan E.,Abraham S.,Roxby D. .2021 .Extending the post-thaw viability of cryoprecipitate. Transfusion, 61 : 1578-1585.
Wang Z.,Du X.,Li C.,Ma L.,Sun P.,Cao H.,Lin F.,Ye S.,Xiao X. .2014 .Coagulation factors and inhibitors in thawed plasma stored at 1-6°C for 5 days in China. , 01 : 274-280.
Wei Z.,Dong G.,Wang F.,Xiao Y.,Fu H.,Yang C. .2023 .Analysis of factors afecting coagulation factors in fresh frozen plasma. Chin. J. Hlth. Lab, 30 : 2000-2002.
Yang J.C.,Li F.Q.,Li M.H.,Ren J.K. .2006 .Biological activities of the coagulation factor VIII, IX in platelet concentrates collected by platelet apheresis during preservation. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 14 : 162-164.
Zhou J. .2012 .Enforce and investigation of whole blood and component blood quality requirements (GB18469-. J. clin. Hematol. (Blood Trans Lab Med), 26 : 572-573.
Zhu L.,Li C.,Wang D. .2019 .Individual diferences of plasma proteins and factors in fresh frozen plasma from Chinese regional blood donors. J. Thromb. Thrombolysis, 47 : 420-426.
0

Citations

0

Downloads

119

Views